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Opioid premedication in dogs prior to endoscopy 
  
ABSTRACT 
Objective 
The effect of premedication with butorphanol or methadone on ease of endoscopic 
duodenal intubation. 
Study Design 
Prospective, randomized, blinded clinical trial 
Animals or Animal population 
Twenty client owned dogs 
Methods 
Dogs were randomly assigned to receive intravenous (IV) premedication with either 
butorphanol (0.4 mg kg-1) or methadone (0.3 mg kg-1). General anaesthesia was induced 
with propofol to effect, and maintained with isoflurane in 100% oxygen. Sedation score 
20 minutes after administering premedication, and induction dose of propofol were 
recorded. Heart rate (HR), mean arterial pressure (MAP), haemoglobin oxygen 
saturation (SaO2), respiratory rate (ƒR) and end-tidal isoflurane concentration (Fe’Iso) 
were recorded every five minutes. Spontaneous lower oesophageal and pyloric sphincter 
opening, presence of gastro-oesophageal and duodeno-gastric reflux, antral peristaltic 
contractions and response to endoscopy were recorded as Yes / No.  Ease of duodenal 
intubation (EDI) was graded on a four point scale. Time (seconds) from the start of 
pyloric intubation to successfully entering the duodenum was recorded. 
Results 
Median EDI score (2.5 ± 1.1 Butorphanol, 4.0 ± 1.0 Methadone, p = 0.035), time (65 ± 
35.5 s Butorphanol, 120 ± 38.1 s Methadone, p = 0.028) and spontaneous pyloric 
sphincter opening (7/10 Butorphanol, 2/10 Methadone, p = 0.035) significantly differed 
between groups. No other significant differences were found.  
Conclusions and clinical relevance 
In these clinical cases duodenal intubation was performed with greater ease, shorter 
time and more frequent spontaneous opening of the pyloric sphincter after 
premedication with butorphanol in comparison to methadone. The use of butorphanol 
facilitated the passage of the endoscope and is therefore recommended for 
premedication prior to upper gastrointestinal tract endoscopy.  
 Keywords: 
Canine; Methadone; Butorphanol; Endoscopy; Pylorus  
Introduction 
Endoscopic examination of the gastrointestinal tract is a commonly performed 
procedure in dogs. The ability to obtain biopsies and to visualise the mucosal surface of 
the intestines without the need for an exploratory laparotomy has advantages in 
potentially already compromised patients (Zoran 2001; Simpson 2005). General 
anaesthesia for these cases however is still a necessity, not only for both the safety and 
comfort of the patient and operator, but also for protection of the equipment (Zoran 
2001). 
 The pyloric sphincter can impede passage of an endoscope from the stomach 
into the duodenum (Donaldson et al. 1993). The aim of pharmacological manipulation 
of pyloric sphincter tone is to optimise conditions to allow easy passage of the 
endoscope into the duodenum. The use of morphine (0.5 mg kg-1) in combination with 
atropine (0.04 mg kg-1) given intramuscularly (IM) results in conditions that make the 
passage of an endoscope through the canine pyloric sphincter more difficult (Donaldson 
et al. 1993). It is therefore often recommended that opioids be avoided as part of the 
premedication prior to general anaesthesia for endoscopy (Zoran 2001; Hall 2008). No 
studies currently compare the use of methadone and butorphanol for premedication 
prior to upper gastrointestinal tract endoscopy despite the recommendation that µ opioid 
agonists be avoided and butorphanol be used for this indication (Kerr 2016). 
Butorphanol is a synthetic opioid partial agonist, its low efficacy at µ opioid 
receptors leads to its classification as a  opioid receptor agonist and a µ opioid receptor 
antagonist (WHO 2006). Butorphanol produces mild sedation when used alone and 
analgesia inferior to that of the full µ agonists (Kerr, 2016). It is therefore best reserved 
for minor elective surgical and diagnostic procedures. 
Methadone is a synthetic opioid agonist with a high affinity for µ opioid 
receptors and a similar potency to morphine. The dextrorotatory enantiomer of 
methadone is an NMDA receptor antagonist, an additional property that is not possessed 
by other µ opioid receptor agonists or butorphanol. When used alone for sedation 
methadone produces only mild sedation and is associated with a high prevalence of 
panting, but less vomiting than morphine (Monteiro et al. 2008; Monteiro et al. 2009). 
The lower prevalence of retching and vomiting in dogs premedicated with methadone 
compared to morphine makes it a good choice for gastrointestinal endoscopy. 
 The purpose of this study was to compare the influence of butorphanol and 
methadone on the ease of passing an endoscope from the stomach through the pyloric 
sphincter into the duodenum of dogs anaesthetised with propofol and isoflurane. We 
hypothesised that butorphanol would result in conditions that better facilitated the 
passing of the endoscope than methadone. 
Materials and methods 
Ethical approval was obtained from the Animal and Welfare Ethical Review 
Board of the ?, UK (VIN/15/021). Informed owner consent was obtained for each dog 
recruited to the study. Based on previously published work (Donaldson et al. 1993) it 
was calculated that we would require 10 dogs per group to detect a difference of one, 
using the scale published by Matz et al. (1991) on the ease of performing endoscopic 
duodenal intubation, at a 95% confidence level with 80% power. 
Animals 
Twenty dogs scheduled for upper gastrointestinal endoscopy involving 
examination of the duodenum were enrolled in this study. All dogs considered eligible 
for the anaesthetic protocol were included. Exclusion criteria included dogs that were 
unsuitable for the anaesthetic protocol and dogs suspected of having gastric or lower 
gastrointestinal tract disease alone and therefore not scheduled for examination of the 
duodenum. 
Study Protocol 
A prospective, randomized, blinded clinical trial was designed. Patients enrolled 
in the study were randomly assigned to one of two groups using an online 
randomisation programme (www.sealedenvelope.com). Group M (n=10) were to 
receive methadone and Group B (n=10) butorphanol as intravenous premedication. 
All dogs underwent physical examination by the same anaesthetist on the day of 
the scheduled procedure and were judged to be suitable for the anaesthetic protocol. 
Dogs were assigned an American Society of Anaesthesiologists (ASA) score (I-V) and 
a body condition score (BCS) using a nine point scale. Food but not water was withheld 
for 24 to 48 hours prior to general anaesthesia, dependent on whether lower 
gastrointestinal endoscopy would be performed. If required, dogs were given three 
peroral doses of a bowel cleansing agent (25 ml/kg/dose, KleanPrep; Norgine, UK) with 
the last dose 12 hours before, and a warm water enema two hours before general 
anaesthesia. A 20Ga catheter (Jelco; Smiths Medical, UK) was placed into either 
cephalic vein. Group M received methadone 0.3 mg kg-1 (Comfortan; Dechra, UK) and 
Group B butorphanol 0.4 mg kg-1 (Alvegesic; Dechra, UK) intravenously (IV) as 
premedication. Treatments were prepared by a second anaesthetist to ensure the 
anaesthetist performing the study remained blinded to group allocations. All treatments 
were diluted to a total volume of 0.05 ml kg-1 using sterile water for injection (Water for 
Injection; Hameln Pharmaceuticals, Germany).  
Dogs were taken to a quiet room and allowed to acclimatize for 10 minutes 
before administration of treatments. Dogs were kept in the same room and monitored 
throughout for any signs of adverse reaction to the treatments. After 20 minutes the 
level of sedation was assessed using a composite sedation scale ranging from 0) no 
sedation  to 15) well sedated (Gurney et al. 2009). Dogs where then moved to the room 
where endoscopy was to be performed. Anaesthesia was induced with Propofol 
(PropoFlo; Abbott,UK) IV given to effect to allow endotracheal intubation. General 
anaesthesia was maintained with Isoflurane (Iso-Vet; Chanelle, Primal Healthcare, UK) 
vaporised in 100% oxygen, given at a variable concentration to maintain an adequate 
depth of anaesthesia, delivered via a Mapleson-D or circle breathing system. Dogs were 
positioned in left lateral recumbency and connected to a multiparameter monitor (PM-
9000Vet; Mindray, China). When the relevant monitoring was attached, endoscopy was 
started. Heart rate (HR), oscillometric mean arterial pressure (MAP), haemoglobin 
oxygen saturation (SaO2), respiratory rate (ƒR) and end-tidal isoflurane concentration 
(Fe’Iso) were recorded every five minutes throughout the test period. Upper 
gastrointestinal tract endoscopy was performed first if lower gastrointestinal tract 
endoscopy was also required. If a response of purposeful movement or swallowing was 
seen during either passage of the endoscope into the stomach or through the pyloric 
sphincter, this was recorded and a 1 mg kg-1 propofol bolus given IV. If an increase of 
greater than 20% in either HR, ƒR or MAP was seen, this was recorded and the inspired 
concentration of isoflurane increased by 0.25% on the vaporiser setting. If evident, the 
presence of gastro-oesophageal reflux was recorded and when the lower oesophageal 
sphincter was visualised it was examined for spontaneous opening. Once through the 
lower oesophageal sphincter and into the stomach the movement of the antrum was 
examined. The endoscope was positioned to clearly visualise the pyloric sphincter and if 
present, reflux from the duodenum into the stomach was recorded. The pyloric sphincter 
was also examined for spontaneous opening. When the pyloric sphincter had been 
visualised a stopwatch was started and the endoscopist advanced the endoscope through 
the pyloric sphincter into the duodenum. The stopwatch was stopped when positive 
confirmation of entering the duodenum could be made. The ease of passing the 
endoscope through the pyloric sphincter was also graded using a four point scale (Matz 
et al. 1991). 1 = immediate entry with minimal manoeuvring required, 2 = rapid entry 
with moderate manoeuvring, 3 = difficult entry with multiple attempts required and 4 = 
no entry after two minutes. Once the duodenum had been entered the study period was 
finished and the general anaesthetic monitored and maintained as deemed appropriate 
for the remainder of the endoscopic examination. At the end of general anaesthesia, 
dogs were disconnected from the anaesthetic machine and recovered in a quiet room.  
Statistical analysis 
Descriptive results of parametric continuous variables are given as the mean ± 
standard deviation (SD) and non-parametric continuous plus categorical variables as the 
median (interquartile range). Computer software (SPSS version 23; IBM Corp, USA) 
was used for statistical analysis. Data was tested for normality using the Shapiro-Wilk 
test. Variables that were normally distributed were tested using Students t-test for 
differences between treatments. Non-normally distributed variables were tested for 
differences between treatments using the Mann-Whitney U test. For categorical 
variables a Fishers exact test was used. Statistical significance was set as a p-value 
<0.05.  
Results 
There was no statistical difference for sex, weight, age, ASA classification and 
BCS between the dogs in either group (Table 1).  
No significant differences were found for sedation scores 20 minutes after drug 
administration, or the dose of propofol required for induction of general anaesthesia, or 
the physiological parameters or the Fe’Iso between groups at the time of passage of the 
scope through the pyloric sphincter (Table 2). 
No significant differences between groups was found for response to passing of 
the endoscope, presence of oesophageal reflux, spontaneous opening of the lower 
oesophageal sphincter, presence of duodenal reflux, and presence of antral movement. 
Spontaneous opening of the pyloric sphincter was significantly different between the 
two groups. Of dogs in Group B 7/10 showed spontaneous opening of the pyloric 
sphincter compared to 2/10 dogs in Group M (p = 0.035) (Table 3). 
The ease of passing the endoscope through the pyloric sphincter differed 
significantly between groups, with significantly greater ease shown for Group B (p = 
0.035). The time taken to pass the endoscope through the pyloric sphincter also differed 
significantly between groups with 65 (65) seconds for Group B and 120 (44) seconds 
for Group M (p = 0.028). (Table 4) 
Discussion 
Compared to methadone at a dose of 0.3 mg kg-1 IV, premedication with 
butorphanol at a dose of 0.4 mg kg-1 IV prior to upper gastrointestinal tract endoscopy, 
resulted in conditions that allowed for easier and quicker passage of the endoscope 
through the canine pyloric sphincter.  
Endogenous opioid peptides are released by neurons of the myenteric plexus, in 
particular neurons that project to circular muscle (Sternini et al. 2004). Opioid receptors 
are found both pre- and post-synaptically on excitatory and inhibitory enteric neurons 
(Holzer 2009). This wide distribution of opioid receptors means that effects of 
exogenous opioids can lead to pyloric muscle spasm or relaxation dependent on which 
pathway is interrupted. Effects on excitatory pathways is via inhibition of acetylcholine 
release, and on inhibitory pathways via inhibition of nitric oxide release (Holzer 2009). 
The distribution of opioid receptor type varies between species and location along the 
gastrointestinal tract (Sternini et al. 2004). Despite this, recommendations to avoid 
opioids prior to endoscopy often do not differentiate between classes of opioid drugs 
(Zoran 2001; Hall 2008). This may mean that the use of opioid drugs that facilitate 
endoscopy and also provide additional comfort for the patient are being overlooked.  
In this study, the use of methadone was associated with significantly longer 
times and reduced ease of passing the endoscope through the pyloric sphincter. This 
finding is consistent with a study of Donaldson et al. (1993) where the use of three 
premedication combinations containing morphine resulted in the most difficulty for 
passage of an endoscope through the pyloric sphincter, compared to nine other 
premedication combinations. Although methadone and not morphine was used in this 
study, their similar activity at opioid receptors should allow for transposition of results.  
Premedication with methadone resulting in more difficult passage of an endoscope 
through the pyloric sphincter is likely due to increased tone of the circular muscles 
(Holzer 2009). Our study supports this view as spontaneous pyloric sphincter opening 
was found to be less frequent in dogs that had received methadone. Increases in 
sphincter muscle tone following µ opioid receptor agonists is supported by the 
administration of the µ opioid receptor antagonist naloxone causing a reduction in 
pyloric sphincter tone and reversing opioid induced constipation (Reynolds et al. 1984; 
Jurna et al. 1992). This finding in dogs is in contrast to that found when hydromorphone 
at a dose of 0.1 mg kg-1 was compared to butorphanol at 0.4 mg kg-1 in cats, where no 
significant difference in ease or time taken to pass the endoscope through the cardiac 
and pyloric sphincters was found (Smith et al. 2004). This shows the importance of 
species variations when thinking about the effect of opioid drugs on gastrointestinal 
activity. 
In contrast to methadone, butorphanol’s intrinsic partial µ opioid receptor 
agonist activity causes only slight increases in gastrointestinal smooth muscle activity 
(WHO 2006). Antagonism of endogenous opioid receptor ligands is another possible 
mechanism to explain the findings seen. Peristaltic activity in the rat intestine is 
inhibited by µ and δ opioid receptor agonists but not  opioid receptor agonists (Holzer 
2009). If the dog’s intestine shows a similar response to  opioid receptor agonists this 
may explain the higher incidence of spontaneous opening of the pyloric sphincter in the 
group receiving butorphanol.  
The reason for no difference in the incidence of lower oesophageal sphincter 
opening is likely due to a difference in the distribution of opioid receptors in 
comparison to the pyloric sphincter (Holzer 2009). The tone of the lower oesophageal 
sphincter is unlikely to have a significant impact on the speed and ease of performing 
endoscopy due to the fact that minimal manipulation of the endoscope is required for 
orientation and passage of the endoscope into the stomach.  
Both groups of dogs in the present study required 1x MAC of isoflurane, this is 
lower than the concentration of inhalation agent required in previous studies where 1.2 
– 1.5x MAC has been required (Lieb et al. 1990; Donaldson et al. 1993). A response to 
passage of the endoscope in this study was defined as either purposeful movement or 
swallowing requiring additional propofol, or changes of greater than 20% in monitored 
physiological variables. Although 6 dogs in the methadone group and 4 dogs in the 
butorphanol group showed a response to passage of the endoscope, this was primarily as 
a transient increase in the heart rate and did not require intervention. Only one dog in 
each group required additional propofol. It can therefore be concluded that a Fe’Iso of 
1x MAC is sufficient to facilitate upper gastrointestinal tract endoscopy following either 
premedication used in this study. 
Although the doses of butorphanol and methadone selected for this study may 
not be considered equipotent, they were selected based on the average dose of each drug 
when used as the sole premedication prior to general anaesthesia at the institution in 
which the study was conducted. This approach, rather than simply using the same dose 
of each drug, makes the doses used clinically relevant. Given that this study investigated 
the effects of the premedication it can be said that the doses used were equi-efficacious 
as there was no difference between groups for the sedation score, induction dose of 
propofol (mg kg-1) or Fe’Iso (%). The doses of butorphanol 0.4 mg kg-1 and methadone 
0.3 mg kg-1 could therefore be considered equipotent in the context of this study. 
The 15 point sedation scale used in this study (Gurney et al. 2009)is an adapted 
version of a previously published 20 point scale (Kuusela et al. 2000). This adapted 
version removes the need to assess relaxation of the jaw tone. The original scale and 
another simplified version that has previously been used to assess sedation in cats (Grint 
et al. 2009), have been found to have good intra- and inter-rater reliability (Wagner et 
al. 2016). Variability was kept to a minimum by one observer assessing sedation level 
in all dogs. An improvement would be the use of a clicker to produce a repeatable noise 
to assess the response to sound rather than a hand clap (Wagner et al. 2016). 
A limitation of the study is that due to the constraints of a teaching hospital 
environment, the endoscopic procedures were performed by seven different 
endoscopists. It has been previously suggested that experience of the person performing 
the endoscopy has a significant effect on the ease of passing the scope through the 
pylorus (Matz et al. 1991). All users performing endoscopy during this study had been 
trained in the use of an endoscope for upper gastrointestinal tract endoscopy and none of 
the endoscopists were novice to the technique or equipment used. The effect of the 
operator performing the endoscopy was investigated, data not presented here, and it was 
found that endoscopist experience was not significantly correlated with either time 
taken or ease of passing the endoscope through the pyloric sphincter in this study. 
This study reports for the first time the use of either butorphanol or methadone, 
and their comparison, for premedication prior to upper gastrointestinal tract endoscopy 
in the dog. It uses updated anaesthetic protocols in comparison to previous studies and 
in clinical rather than experimental animals. Both methadone and butorphanol resulted 
in adequate anaesthesia at 1x MAC of isoflurane, without any difference in sedation 
score. Improved conditions for endoscopy were found for the butorphanol group and 
might result in a better experience for both the patient and endoscopist. In conclusion, in 
these clinical cases duodenal intubation was performed with greater ease, shorter time 
and more frequent spontaneous opening of the pyloric sphincter after premedication 
with butorphanol in comparison to methadone, showing that the use of opioids should 
not necessarily be avoided in patients undergoing endoscopy.  
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Parameter Group B Group M p value 
Weight 20.0 ± 12.9 14.2 ± 8.4 0.247 
Age 80 ± 49 64 ± 47 0.453 
ASA 2 ± 1 2 ± 1 0.303 
BCS 4 ± 5 3 ± 2 0.155 
Gender 6 M / 4 F 7 M / 3 F 0.500 
Table 1 Weight (kg), age (months), ASA classification (I-V), body condition socre 
(BCS, 1-9) and gender (M male, F female) of dogs premedicated with either 0.4 mg kg-1 
butorphanol (Group B) or 0.4 mg kg-1 methadone (Group M) intravenously 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Group B Group M p value 
Sedation Score 5.3 ± 2 7.2 ± 2.5 0.082 
Induction Dose 4.3 ± 1.2 5.8 ± 1.9 0.056 
HR 98 ± 27 86 ± 20 0.274 
ƒR 13 ± 8 16 ± 10 0.405 
SpO2 98 ± 1 98 ± 0.5 0.631 
MAP 67 ± 4 66 ± 10 0.856 
Fe’Iso 1.22 ± 0.21 1.28 ± 0.22 0.531 
Table 2 Sedation score (/15, 0) no sedation to 15) well sedated, induction dose of 
propofol (mg/kg), heart rate (HR), respiratory rate (ƒR), haemoglobin-oxygen saturation 
(SpO2) %, mean arterial pressure (MAP) mmHg and end-tidal isoflurane concentration 
(Fe’Iso) % at time of passage of an endoscope through the pyloric sphincter in dogs 
premedicated with either 0.4 mg kg-1 butorphanol (Group B) or 0.4 mg kg-1 methadone 
(Group M) intravenously. 
 
 
 
 
 
 
 
 
 
 Group Yes No p value 
Response to passing the Endoscope B 4 6 0.328 
M 6 4  
Oesophageal reflux present B 2 8 0.500 
M 1 9  
Spontaneous opening of the lower 
oesophageal sphincter 
B 5 5 0.500 
M 4 6  
Duodenal reflux present B 6 4 0.085 
M 2 8  
Spontaneous opening of the pyloric 
sphincter 
B 7 3 0.035* 
M 2 8  
Antral movement present B 2 8 0.314 
M 4 6  
Table 3 Observations made during upper gastrointestinal tract endoscopy in dogs after 
premedication with either 0.4 mg kg-1 butorphanol (Group B) or 0.4 mg kg-1 methadone 
(Group M) intravenously. * indicates a significant difference between the groups (p < 
0.05).  
 
 
 
 
 
 
 Ease of passing the endoscope through the pyloric sphincter  
Score 1 2 3 4 
B (n =10) 4 1 4 1 
M (n = 10) 1 0 4 5 
Table 4 Ease of passing the endoscope through the pyloric sphincter grade (1-4) in dogs 
after premedication with either 0.4 mg kg-1 butorphanol (Group B) or 0.4 mg kg-1 
methadone (Group M) intravenously. 
Scoring 1 = immediate entry with minimal manoeuvring required, 2 = rapid entry with 
moderate manoeuvring, 3 = difficult entry with multiple attempts required and 4 = no 
entry after two minutes. (Matz et al. 1991). 
